loadpatents
name:-0.019577026367188
name:-0.011847019195557
name:-0.009192943572998
Zaks; Tal Patent Filings

Zaks; Tal

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zaks; Tal.The latest application filed is for "tropical disease vaccines".

Company Profile
9.10.21
  • Zaks; Tal - Newton MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Tropical Disease Vaccines
App 20220257746 - Ciaramella; Giuseppe ;   et al.
2022-08-18
CHIKV RNA vaccines
Grant 11,364,292 - Ciaramella , et al. June 21, 2
2022-06-21
HMPV/hPIV3 mRNA vaccine composition
Grant 11,351,242 - Panther , et al. June 7, 2
2022-06-07
Concatemeric Peptide Epitope Rnas
App 20220152178 - Ciaramella; Giuseppe ;   et al.
2022-05-19
Zika virus RNA vaccines
Grant 11,278,611 - Ciaramella , et al. March 22, 2
2022-03-22
Chikungunya virus RNA vaccines
Grant 11,235,052 - Ciaramella , et al. February 1, 2
2022-02-01
Chikv Rna Vaccines
App 20200368344 - Ciaramella; Giuseppe ;   et al.
2020-11-26
Zika Virus Mrna Vaccines
App 20200368343 - Ciaramella; Giuseppe ;   et al.
2020-11-26
USE OF MRNAS ENCODING OX40L, IL-23 AND IL-36gamma IN COMBINATION WITH IMMUNE CHECKPOINT BLOCKADE FOR TREATING CANCER
App 20200360481 - MEEHAN; Robert ;   et al.
2020-11-19
Chikungunya Virus Rna Vaccines
App 20200289639 - Ciaramella; Giuseppe ;   et al.
2020-09-17
Zika Virus Rna Vaccines
App 20200289638 - Ciaramella; Giuseppe ;   et al.
2020-09-17
CHIKV RNA vaccines
Grant 10,702,597 - Ciaramella , et al.
2020-07-07
Chikungunya virus RNA vaccines
Grant 10,675,342 - Ciaramella , et al.
2020-06-09
Zika virus RNA vaccines
Grant 10,517,940 - Ciaramella , et al. Dec
2019-12-31
Zika RNA vaccines
Grant 10,449,244 - Ciaramella , et al. Oc
2019-10-22
Chikagunya virus RNA vaccines
Grant 10,238,731 - Ciaramella , et al.
2019-03-26
Infectious Disease Vaccines
App 20190060438 - Ciaramella; Giuseppe ;   et al.
2019-02-28
Concatemeric Peptide Epitope Rnas
App 20190008938 - Ciaramella; Giuseppe ;   et al.
2019-01-10
Zika Virus Rna Vaccines
App 20190008946 - Ciaramella; Giuseppe ;   et al.
2019-01-10
Chikungunya Virus Rna Vaccines
App 20190008947 - Ciaramella; Giuseppe ;   et al.
2019-01-10
Denv Rna Vaccines
App 20180344838 - Ciaramella; Giuseppe ;   et al.
2018-12-06
Chikv Rna Vaccines
App 20180344839 - Ciaramella; Giuseppe ;   et al.
2018-12-06
Zika virus RNA vaccines
Grant 10,124,055 - Ciaramella , et al. November 13, 2
2018-11-13
Cancer Vaccines
App 20180318409 - Valiante; Nicholas ;   et al.
2018-11-08
Zika Rna Vaccines
App 20180280496 - CIARAMELLA; GIUSEPPE ;   et al.
2018-10-04
Chikagunya Virus Rna Vaccines
App 20180008694 - Ciaramella; Giuseppe ;   et al.
2018-01-11
Zika Virus Rna Vaccines
App 20170340724 - Ciaramella; Giuseppe ;   et al.
2017-11-30
Combination Therapies for Treating Hematologic Malignancies Using Pyridopyrimidinone Inhibitors of PI3K/mTOR with Bendamustine and/or Rituximab
App 20140302012 - DeCillis; Arthur ;   et al.
2014-10-09
Method of Treating Lymphoma Using Pyridopyrimidinone Inhibitors of PI3K/mTOR
App 20140296265 - DeCillis; Arthur ;   et al.
2014-10-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed